Evidence map›Paper›PMID 37706330›Full record

ArticleHaematologica2024

Amphiregulin as a biomarker for monitoring lifethreatening acute graft-

Shernan G Holtan, Najla El Jurdi, Armin Rashidi, Brian C Betts, Connor Demorest, John P Galvin, Margaret L MacMillan, Daniel J Weisdorf, Angela Panoskaltsis-Mortari, Michael A Pratta

Open access · goldAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Haematologica, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Shernan G HoltanUniversity of Minnesota, Adult Blood and Marrow Transplant and Cell Therapy Program, Minneapolis, MN.
Najla El JurdiUniversity of Minnesota, Adult Blood and Marrow Transplant and Cell Therapy Program, Minneapolis, MN.
Armin RashidiUniversity of Minnesota, Adult Blood and Marrow Transplant and Cell Therapy Program, Minneapolis, MN; Fred Hutchinson Cancer Center.
Brian C BettsUniversity of Minnesota, Adult Blood and Marrow Transplant and Cell Therapy Program, Minneapolis, MN.
Connor DemorestBiostatistics Core, Masonic Cancer Center, University of Minnesota, Minneapolis, MN.
John P GalvinIncyte Corporation, Wilmington, DE.
Margaret L MacMillanUniversity of Minnesota, Pediatric Blood and Marrow Transplant and Cell Therapy Program, Minneapolis, MN.
Daniel J WeisdorfUniversity of Minnesota, Adult Blood and Marrow Transplant and Cell Therapy Program, Minneapolis, MN.
Angela Panoskaltsis-MortariUniversity of Minnesota, Pediatric Blood and Marrow Transplant and Cell Therapy Program, Minneapolis, MN.
Michael A PrattaIncyte Corporation, Wilmington, DE.
University of Minnesota · USNational Marrow Donor Program · USIncyte (United States) · US

Funding

Women's CancerP30CA077598 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI Timothy C. Hallstrom · 1998 to 2026
$100.4M
Trial Design and Biostatistical Support CoreP01CA065493 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI Mark J Osborn · 1995 to 2026
$48.2M
University of Minnesota Clinical and Translational Science Institute (UMN CTSI)UL1TR002494 · NCATS · UNIVERSITY OF MINNESOTA · PI BLAZAR, BRUCE R, WEISDORF, DANIEL J · 2018 to 2022
$34.9M
NCATS NIH HHS UL1 TR002494NCI NIH HHS P01 CA065493NCI NIH HHS P30 CA077598
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AmphiregulinBiomarkersGraft vs Host DiseaseAcute DiseaseAdultFemaleHematopoietic Stem Cell TransplantationHumansMaleMiddle AgedProspective StudiesAmphiregulinBiomarkers

Identifiers

PMID37706330
PMCPMC11063869
OpenAlexW4386726681

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.